Literature DB >> 22954611

The kidney in HIV infection: beyond HIV-associated nephropathy.

Christina M Wyatt1.   

Abstract

Acute kidney injury (AKI) and chronic kidney disease (CKD) are more common in HIV-infected persons than in the general population. AKI is associated with poor health outcomes, including increased risk of heart failure, cardiovascular events, end-stage renal disease (ESRD), and mortality. The most common causes of AKI in HIV-infected persons are systemic infections and adverse drug effects. The prevalence of CKD is rising in the HIV-infected population and CKD is increasingly likely to be caused by comorbid conditions, such as diabetes and hypertension, that frequently cause CKD in the general population. Guidelines for CKD screening in HIV-infected patients are being revised. It is currently recommended that all patients be screened for creatinine-based estimates of glomerular filtration rate and for urine protein at the time of HIV diagnosis. Annual screening is recommended for high-risk patients. Hemodialysis, peritoneal dialysis, and kidney transplantation are all options for treating ESRD in HIV-infected patients. Hemodialysis and peritoneal dialysis offer similar survival in HIV-infected patients with ESRD. In selected patients with well-controlled HIV infection, kidney transplantation is associated with survival intermediate between that in the overall transplant population and that among transplant recipients older than 65 years. This article summarizes a presentation by Christina M. Wyatt, MD, at the IAS-USA continuing medical education program held in Chicago in May 2012, describing AKI and CKD using case illustrations.

Entities:  

Mesh:

Year:  2012        PMID: 22954611      PMCID: PMC6148945     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  11 in total

1.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 2.  Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Authors:  Ryan D Cooper; Natasha Wiebe; Nathaniel Smith; Philip Keiser; Saraladevi Naicker; Marcello Tonelli
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

3.  Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

Authors:  Amanda Mocroft; Ole Kirk; Peter Reiss; Stephane De Wit; Dalibor Sedlacek; Marek Beniowski; Jose Gatell; Andrew N Phillips; Bruno Ledergerber; Jens D Lundgren
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

4.  Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

Authors:  Nora Franceschini; Sonia Napravnik; Joseph J Eron; Lynda A Szczech; William F Finn
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

5.  Outcomes of kidney transplantation in HIV-infected recipients.

Authors:  Peter G Stock; Burc Barin; Barbara Murphy; Douglas Hanto; Jorge M Diego; Jimmy Light; Charles Davis; Emily Blumberg; David Simon; Aruna Subramanian; J Michael Millis; G Marshall Lyon; Kenneth Brayman; Doug Slakey; Ron Shapiro; Joseph Melancon; Jeffrey M Jacobson; Valentina Stosor; Jean L Olson; Donald M Stablein; Michelle E Roland
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 91.245

6.  The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.

Authors:  Lynda Anne Szczech; Samir K Gupta; Ramez Habash; Antonio Guasch; Robert Kalayjian; Richard Appel; Timothy A Fields; Laura P Svetkey; Katherine H Flanagan; Paul E Klotman; Jonathan A Winston
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Observations on a cohort of HIV-infected patients undergoing native renal biopsy.

Authors:  Adam R Berliner; Derek M Fine; Gregory M Lucas; M Hafizur Rahman; Lorraine C Racusen; Paul J Scheel; Mohamed G Atta
Journal:  Am J Nephrol       Date:  2008-01-04       Impact factor: 3.754

8.  HIV care and the incidence of acute renal failure.

Authors:  Jennifer Roe; Lucy J Campbell; Fowzia Ibrahim; Bruce M Hendry; Frank A Post
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

9.  Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.

Authors:  Christina M Wyatt; Raymond R Arons; Paul E Klotman; Mary E Klotman
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

10.  Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.

Authors:  Sayed Tabatabai; C John Sperati; Mohamed G Atta; Kashif Janjua; Christopher Roxbury; Gregory M Lucas; Derek M Fine
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-01       Impact factor: 8.237

View more
  14 in total

Review 1.  Antiretroviral therapy: when to start.

Authors:  Christopher J Sellers; David A Wohl
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.

Authors:  Rebecca T Veenhuis; Jacquie Astemborski; Michael A Chattergoon; Paige Greenwood; Marissa Jarosinski; Richard D Moore; Shruti H Mehta; Andrea L Cox
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

3.  End-stage renal disease among HIV-infected adults in North America.

Authors:  Alison G Abraham; Keri N Althoff; Yuezhou Jing; Michelle M Estrella; Mari M Kitahata; C William Wester; Ronald J Bosch; Heidi Crane; Joseph Eron; M John Gill; Michael A Horberg; Amy C Justice; Marina Klein; Angel M Mayor; Richard D Moore; Frank J Palella; Chirag R Parikh; Michael J Silverberg; Elizabeth T Golub; Lisa P Jacobson; Sonia Napravnik; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2014-11-18       Impact factor: 9.079

4.  Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.

Authors:  Katsushi Tajima; Kei Kohno; Yosuke Shiono; Ikuko Suzuki; Yuichi Kato; Yuki Hiroshima; Masakazu Yamamoto; Hiroya Ohtake; Akiko Iwaba; Mitsunori Yamakawa; Takeo Kato
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 5.  APOL1 and kidney cell function.

Authors:  Vinod Kumar; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

Review 6.  Antiretroviral therapy and the kidney.

Authors:  Christina M Wyatt
Journal:  Top Antivir Med       Date:  2014 Jun-Jul

Review 7.  Human immunodeficiency virus and pulmonary arterial hypertension.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-08-21

Review 8.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.

Authors:  Nazik Elmalaika Os Husain; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-12-17

9.  Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Authors:  Anton Pozniak; Jose R Arribas; Joseph Gathe; Samir K Gupta; Frank A Post; Mark Bloch; Anchalee Avihingsanon; Gordon Crofoot; Paul Benson; Kenneth Lichtenstein; Moti Ramgopal; Ploenchan Chetchotisakd; Joseph M Custodio; Michael E Abram; Xuelian Wei; Andrew Cheng; Scott McCallister; Devi SenGupta; Marshall W Fordyce
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

10.  Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.

Authors:  Yewulsew Mekuria; Daniel Yilma; Zeleke Mekonnen; Tesfaye Kassa; Lealem Gedefaw
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.